SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines is experiencing significant market volatility and high trading volume as investors react to a transformational earnings report featuring robust revenue guidance and the integration of its recent acquisition. The community is actively debating the timing of potential major contract awards, with bullish sentiment driven by the company's ambitious 2026 outlook and its unique position in lunar infrastructure, while short sellers remain focused on execution risks and past delays.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is currently seeing volatile trading as investors weigh concerns over Medicare Advantage reimbursement rates and regulatory pressures against the company's long-term potential as a defensive sector leader. The community is actively debating whether current price levels represent a significant buying opportunity ahead of upcoming policy decisions, with many participants closely monitoring institutional positioning and sector-wide sentiment.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings shares are facing volatility as the market reacts to intense competition from prediction markets like Kalshi and Polymarket, which are currently fueling debate over regulatory oversight and their long-term impact on traditional sportsbook revenue. While DraftKings is leaning into its own 'Super App' strategy to capture market share and enhance margins, community sentiment remains split between investors betting on a sports-betting rebound and those concerned by persistent insider selling and the broader threat to the existing legislative moat.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

VCX is experiencing significant volatility and aggressive upside momentum as retail traders speculate on its high-profile private equity holdings like Anthropic, OpenAI, and SpaceX. While the community is debating the stock's massive premium over its net asset value and the impact of a six-month lockup period on the majority of existing shares, many are actively monitoring technical chart patterns and volume spikes to identify entry and exit points for what they perceive as a high-risk, high-reward trading opportunity.

The Estée Lauder Companies, Inc. engages in the manufacture of skin care, makeup, fragrance and hair care products. It sells products under Estée Lauder, Clinique, Origins, MAC, Bobbi Brown, La Mer, Jo Malone London, Aveda and Too Faced. The company was founded by Estee Lauder and Joseph Lauder in 1946 and is headquartered in New York, NY.

Estee Lauder Cos., Inc. - Ordinary Shares - Class A

Estee Lauder Cos. Inc

Este Lauder is trending following reports that it is nearing a merger deal with Puig, the parent company of Jean Paul Gaultier, sparking intense community debate over the potential impact on shareholder value. While some investors view the deal as a significant turnaround catalyst, others are actively questioning whether the merger will leave existing shareholders with diluted equity or meaningful long-term upside.

Far below the surface, where light no longer reaches and noise collapses into silence, the Sperm Whale endures.  It does not rely on speed or spectacle. It survives through mass, intelligence, and absolute awareness of its surroundings.  This project is shaped by the same principle — strength formed under pressure, movement guided by understanding, and conviction built where others cannot remain.  While the surface reacts, the deep decides.

The Sperm Whale

The SPERMWHALE token is sparking polarized debate as traders contrast its resilience against broader market volatility with concerns regarding its speculative nature. Community sentiment remains split between those observing quiet accumulation patterns and those skeptical of its long-term viability.

WeRide, Inc. operates as an investment holding company. It engages in the sale of autonomous driving vehicles, primarily including robobuses, robotaxis, robosweepers and related sensor suites. The company was founded by Tony Xu Han and Yan Li in February 2017 and is headquartered in Guangzhou, China.

WeRide Inc. - ADR

WeRide is currently trending due to its aggressive global expansion, highlighted by live driverless robotaxi operations with Uber in the Middle East and new partnerships with Grab in Singapore. While the community is actively debating the company's long-term valuation and future revenue potential, investor sentiment remains mixed as they wait for more transparency from leadership regarding the 2026 growth roadmap.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

GLD is experiencing significant volatility and a sharp sell-off, driven by a combination of surging bond yields, a strengthening dollar, and massive capital rotation into the energy sector amid escalating Middle East tensions. Community sentiment is deeply divided, with some investors panic-selling as gold loses its safe-haven appeal, while others view the heavy liquidation and extreme oversold conditions as a rare contrarian buying opportunity for long-term physical accumulation.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals is rallying as shareholders celebrate a major leadership overhaul, including the appointment of Kevin Tang as CEO, which the community views as a critical step toward fiscal discipline and a potential sale of the company. Investors are actively discussing the removal of the previous CEO and the new leadership's decision to forgo traditional compensation, signaling to the market that the company is now positioning itself to maximize shareholder value.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. It operates through the Steelmaking and Other Businesses segments. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs is facing intense volatility as investors debate the impact of major insider share sales by leadership alongside the ongoing market anticipation for a potential strategic partnership or asset deal with POSCO. While some retail traders are aggressively buying the dip, citing strong forward demand and undervalued asset potential, others are concerned about the company's debt levels and a lack of clear catalysts to break the current downward trend.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Tivic Expands Intellectual Property Portfolio

Tivic Health Systems, Inc. (Nasdaq: TIVC), a diversified therapeutics company, today announced it is expanding its intellectual property portfolio with the recent filing of two additional patent...

Tivic Health to Report Third Quarter 2025 Financial Results on November 14th Via Conference Call and Webcast

Tivic Health Systems, Inc. (Nasdaq: TIVC), a diversified immunotherapeutics company, today announced that it will report its third quarter results for 2025 via pre-recorded conference call and...

Tivic CEO, Jennifer Ernst, to Join Panel at 8th Annual Northwell Health Innovation Constellation Forum on Thursday, Oct. 23

Tivic Health Systems, Inc. (Nasdaq: TIVC), a diversified immunotherapeutics company, today announced that CEO, Jennifer Ernst, will participate in the eighth annual Constellation Forum, a global...

Tivic Receives Two Investigational New Drug Applications for Entolimod for the Treatment of Acute Radiation Syndrome (ARS) and Advanced Cancers

Tivic Health Systems, Inc. (Nasdaq: TIVC), a diversified immunotherapeutics company, today announced it has received, from Statera Biopharma, two investigational new drug applications (INDs) for its...

Tivic Health Advances Discussions on Use of Entolimod as a Radiation Countermeasure at Military Health System Research Symposium 2025

Tivic Health Systems, Inc. (Nasdaq: TIVC), a diversified therapeutics company, is proud to announce it advanced discussions with key US Government agencies through its participation in the 2025...

Shares of Tivic Health Systems, Inc. (TIVC) doubled on Tuesday after the company <a target="_blank" rel="noopener noreferrer nofollow" href="https://ir.tivichealth.com/tivic-health-reports-white-house-briefing-and-fda-meetings-secured-positive-interest-in-potential-military-and-defense-applications-of-its-product-candidates/">said</a> it has garnered “significant positive interest” in potential military and defense applications for its biologic and bioelectronic product candidates following two meetings held in Washington, D.C.Tivic Health provided briefings to senior leadership at the White House and the Food and Drug Administration (FDA) in Washington, D.C. on April 17th.During the meeting with the White House, the company highlighted the need for advanced treatments for acute radiation syndrome in the United States and its allied countries.Tivic Health’s biopharma program’s lead product candidate, Entolimod, is in late-stage studies for the treatment of acute radiation syndrome.Tivic is also preparing to initiate a phase 2 clinical study for Entolimod for the treatment of Neutropenia, a condition characterized by lower-than-normal levels of neutrophils, a type of white blood cell essential for combating infections.The company also discussed the potential for expedited pathways and support for export opportunities for Entolimod and Tivic’s non-invasive cervical vagus nerve stimulation (ncVNS) technology in a separate meeting with senior leaders of the FDA. &nbsp;Tivic Health’s ncVNS program is advancing medical devices to provide treatments for inflammatory, cardiac, and neurologic disorders.The company said that vagus nerve stimulation has shown “strong potential” in the treatment of post-traumatic stress disorder (PTSD), a neurologic disorder of interest to the military.Tivic CEO Jennifer Ernst said that the meetings were informal in nature and more discussions are expected as the company’s Entolimod and ncVNS medical programs progress toward potential FDA approval.On Stocktwits, retail sentiment around Tivic Health remained bearish over the past 24 hours while message volume remained at ‘extremely low’ levels.<figure class="image"><img style="aspect-ratio:647/145;" src="https://news.stocktwits-cdn.com/Screenshot_2025_04_22_at_12_05_02_PM_png_89e18ee138.webp" alt="TIVC's Sentiment Meter and Message Volume as of 12:05 p.m. ET on April 22, 2025 | Source: Stocktwits" width="647" height="145"><figcaption>TIVC's Sentiment Meter and Message Volume as of 12:05 p.m. ET on April 22, 2025 | Source: Stocktwits</figcaption></figure><a href="https://stocktwits.com/symbol/TIVC">TIVC stock</a> is up by over 19% so far this year but down by over 65% over the past 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/rivian-expands-board-adds-aidan-gomez-as-director/chQSuj1RbXk">Rivian Expands Board, Adds Cohere CEO Aidan Gomez As Director: But Retail Stays Bearish</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

Rising stock market chart on a trading board background.

Tivic Health Stock Doubles After Briefings To Senior Leadership At White House, FDA: But Retail Stays Bearish

During the meeting with the White House, the company highlighted the need for advanced treatments for acute radiation syndrome in the United States and its allied countries.

Equity

Shares of The Real Good Food Company ($RGF) dived nearly 65% on Monday as the company announced it received a delisting notice from The Nasdaq, dampening retail sentiment.Real Good Food, a maker of refrigerated foods, said it was no longer in compliance with Nasdaq Listing 5250(c)(1) for failure to file periodic financial reports.Trading in its common stock on Nasdaq will be suspended on January 7.Its common stock is expected to commence trading on the Pink Open Market operated by the OTC Markets Group Inc. (“OTC”), referred to as the “pink sheets,” commencing on January 7.The company warned that trading may ultimately move to OTC’s “Expert Market,” where quotes for the company’s common stock will no longer be available for public viewing.Retail sentiment on Stocktwits seemed bearish with commenters expressing surprise given its recent reverse stock split.<stembedurl>https://stocktwits.com/DisgruntledbutzenDavid/message/599043071</stembedurl>Last month, Real Good Food announced a 12-to-reverse stock split, sparking retail chatter on Stocktwits. According to a company statement, the stock split consisted of its Class A common stock, par value $0.0001, and Class B common stock, par value $0.0001, set to become effective at 5:00 pm ET on January 3. The stock split was to affect all holders of its common stock uniformly, the company said.Real Good Food posted a loss per share of $0.50 for its third quarter, compared to the $0.20 that analysts expected.Real Good Food stock is down nearly 70% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Real Good Food Stock Dives On Nasdaq Delisting: Retail Mood Sours 

The company warned that trading may ultimately move to OTC’s “Expert Market,” where quotes for the company’s common stock will no longer be available for public viewing.

Tivic Health Systems, Inc. operates as a bio-electronic health-tech company, which develops micro current therapy solutions for chronic diseases and conditions. The company was founded by Jennifer Ernst and John Claude on September 22, 2016 and is headquartered in Fremont, CA.

TIVC
Tivic Health Systems Inc

Feed

News

Sentiment

Fundamentals

Info

Latest TIVC News

TIVCTivic Health Systems Inc